Execs Need To Heed Park Doctrine – Former FDA Officials
This article was originally published in The Pink Sheet Daily
Executive Summary
Park doctrine paves the way for FDA to charge top executives with violations, even if they had no knowledge of them.
You may also be interested in...
Former Purdue Execs Fight Exclusion From Gov't Programs After OxyContin Case
The three former Purdue Pharma executives who pled guilty to misbranding OxyContin are battling the government for the ability to work in the health care sector. They have sued HHS for barring them from participation in government health programs for 12 years
Solvay's Androgel REMS Proposal May Need More Restrictions - Cmte.
Solvay may need a more restrictive Risk Evaluation and Mitigation Strategy for AndroGel 1% to adequately warn against the danger of secondary transfer of the testosterone gel, according to some members of FDA's Pediatric Advisory Committee